Klotho Neurosciences, Inc.
KLTO
$0.47
-$0.02-3.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -714.37% | -538.96% | -769.30% | -514.62% | -104.22% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,871.74% | 1,261.33% | -- | 2,039.10% | -- |
| Change in Net Operating Assets | -1,358.90% | -210.49% | -42.21% | -156.11% | -127.51% |
| Cash from Operations | -398.63% | -1,358.73% | -559.34% | -527.68% | -112.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 100.00% | -616.74% | 81.52% | 45.25% |
| Cash from Investing | 100.00% | 100.00% | -616.74% | 81.52% | 45.25% |
| Total Debt Issued | 268.11% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,225.16% | -100.00% | 75.00% | -- | -45.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -89.11% | -- | 211.56% | -- | -- |
| Cash from Financing | 557.76% | 1,722.47% | 794.54% | -- | 299.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 842.43% | 538.73% | 183.42% | 110.23% | 576.84% |